Peptide Protocols

Vesugen Protocol: How to Cycle It, Timing & What to Expect

A Vesugen protocol follows a short-course bioregulator model, not a continuous daily regimen. Depending on the approach, cycles run 10 to 20 days in the traditional format or 4 to 8 weeks in the extended injectable format, each followed by a structured rest before the next course. Dosing is once daily in the morning, with goal and individual response shaping where someone lands on the range. This guide explains the cycle structure, timing principles, phase design, what to expect across a course, and the common mistakes people make, while leaving the personalized dose and exact cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 9 min read

Triptorelin Protocol: How to Cycle It, Timing & What to Expect

A Triptorelin protocol looks very different depending on why it is being used. For post-cycle therapy, it is a single-dose intervention followed by a recovery window of roughly ten to twelve weeks. For clinical indications like prostate cancer or endometriosis, it is a sustained suppressive protocol running for months using extended-release depot formulations dosed monthly, quarterly, or semi-annually. Both contexts are covered here: the cycle shape, the frequency principles, what each phase accomplishes, and what to expect across the timeline, with the personalized dose built in the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Tirzepatide Protocol: How to Cycle It, Timing & What to Expect

A tirzepatide protocol follows a structured titration arc rather than a fixed starting dose. It begins at the lowest available dose for the first four weeks to allow the body to adapt to dual GLP-1 and GIP receptor activation, then steps up in consistent increments every four weeks until reaching an individually determined maintenance dose. Dosing is once weekly throughout, grounded in the compound's roughly five-day half-life, and continuous long-term use is the clinical norm rather than defined on-off cycles. This guide explains how a tirzepatide cycle is structured from initiation through maintenance, what the titration phases look like, what to expect week by week, and where the common mistakes happen, leaving your specific dose, cycle length, and schedule to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Thymosin Beta-4 Protocol: How to Cycle It, Timing & What to Expect

A Thymosin Beta-4 protocol is structured as a loading phase followed by a maintenance phase, with active cycles running four to six weeks for acute injury goals or eight to twelve weeks for chronic repair, followed by a rest period of at least six weeks. Full-length TB4 requires daily dosing due to its short half-life, while its fragment TB-500 is commonly run two to three times per week during loading and once per week during maintenance. The protocol shape and frequency shift depending on whether the goal is acute injury recovery, chronic tissue repair, or long-term protective support, and the personalized dose is built in the MyPeptidePal Protocol Creator rather than stated here.

Protocols By Compound 10 min read

Thymosin Alpha Protocol: How to Cycle It, Timing & What to Expect

A Thymosin Alpha-1 protocol is typically structured as an eight to twelve week cycle at a twice-weekly injection frequency, followed by a four-week break, though chronic immune conditions are often managed on three to six month timelines. Each dose supports immune activity for roughly two to three days, which is why the twice-weekly rhythm is standard. The exact dose depends on your goal, whether general immune support, acute illness recovery, or a chronic condition, and is built for you in the MyPeptidePal Protocol Creator rather than fixed here.

Protocols By Compound 10 min read

Thymalin Protocol: How to Cycle It, Timing & What to Expect

A Thymalin protocol runs as a short, intensive daily course rather than a long sustained cycle. Most protocols use five to ten consecutive daily administrations, then stop completely for a rest period ranging from two weeks to several months before repeating. There is no loading phase or maintenance phase: the full course is administered daily throughout, then a clean break follows. The exact dose depends on the goal, whether that is seasonal immune support, a longevity course, or recovery from immune suppression, and is built individually in the MyPeptidePal Protocol Creator rather than fixed at a single number for everyone.

Protocols By Compound 11 min read

Testagen Protocol: How to Cycle It, Timing & What to Expect

A Testagen protocol comes in two distinct shapes: a short bioregulator cycle of 10 to 20 days followed by a 3 to 6 month break, or a longer subcutaneous titration cycle running 8 to 16 weeks with a 1 to 3 month off period. Both use once-daily administration throughout the active window, with the goal and delivery route determining which framework fits. This guide covers how each cycle is structured, what drives the dose, what to expect week by week, and the mistakes most people make, while leaving the personalized dose and cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

Teriparatide Protocol: How to Cycle It, Timing & What to Expect

A teriparatide protocol runs as a continuous daily therapy, not a short cycle with scheduled breaks. Most courses span up to 24 months, with a single subcutaneous injection taken once daily at a consistent time, typically in the evening. There is no loading-then-maintenance structure in the way research peptides use those terms: the injection frequency stays consistent from day one through the end of the treatment course. When the active phase ends, transitioning immediately to an antiresorptive agent is a critical part of the full protocol, because the bone density gains built during treatment need a consolidation phase to hold.

Protocols By Compound 10 min read

Tesamorelin Protocol: How to Cycle It, Timing & What to Expect

A Tesamorelin protocol typically runs 8 to 12 weeks of once-daily subcutaneous injections taken in the evening before bed, starting with a gradual titration phase that builds to a maintenance level over the first few weeks, then holding there for the rest of the active period. After the active cycle, a structured off-cycle break resets receptor sensitivity before the next round begins. This guide covers how the cycle is structured, what determines the dose, the evening timing rationale, what to expect week by week, and the mistakes that undercut results, while leaving the personalized dose and schedule to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Tesamorelin + Ipamorelin Protocol: How to Cycle It, Timing & What to Expect

A tesamorelin and ipamorelin protocol typically runs 8 to 12 weeks on a 5-days-on, 2-days-off weekly schedule, dosed once nightly 30 to 90 minutes before sleep to align with the body's natural nocturnal growth hormone pulse. The cycle follows a graduated two-phase structure: an acclimation phase for the first four weeks at a lower combined dose, stepping up to a target maintenance dose for the remainder, followed by a break of four to eight weeks before restarting. This guide covers the full cycle structure, timing and frequency principles, what to expect week by week, and the common mistakes people make, while leaving the personalized dose, schedule, and cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

TB-500 Frag Protocol: How to Cycle It, Timing & What to Expect

TB-500 Frag is the colloquial name for TB-500, a synthetic peptide replicating the active fragment of Thymosin Beta-4. A typical protocol runs in two phases: a loading phase of four to six weeks dosed twice weekly, followed by a maintenance phase at reduced frequency, then an off-cycle break of four to eight weeks before repeating. The exact dose depends on whether the goal is acute injury recovery or chronic tissue remodeling, the user's experience level, and the delivery route, and is built in the MyPeptidePal Protocol Creator rather than fixed for everyone.

Protocols By Compound 10 min read

SS-31 Protocol: How to Cycle It, Timing & What to Expect

An SS-31 protocol is typically structured as a cycle of eight to twelve weeks, dosed three times per week for general wellness goals or daily for more intensive therapeutic applications, with a brief titration window in the first one to two weeks , titration meaning you start at a lower dose and step up over that period before settling into the target dose. Because mitochondrial benefit from SS-31 appears to persist well beyond the treatment window, off-cycle breaks are optional rather than physiologically required, though many people build in a rest month for practical and precautionary reasons. This guide covers the full cycle structure, timing and frequency principles, what to expect week by week, and the common mistakes people make, while leaving the personalized dose, schedule, and exact cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Survodutide Protocol: How to Cycle It, Timing & What to Expect

Survodutide is a once-weekly subcutaneous injection built around two consecutive phases: a gradual escalation phase lasting roughly 20 weeks, where the dose steps up at regular intervals to protect GI tolerability, followed by a continuous maintenance phase that extends well beyond that. There is no defined off-cycle break; treatment runs continuously for the full protocol duration, which in Phase 3 trials reaches 76 weeks. The dose is determined by goal, GI tolerance history, and individual escalation pace, and the personalized starting point and target are built in the MyPeptidePal Protocol Creator rather than set to a single number that fits everyone.

Protocols By Compound 10 min read

Sermorelin Protocol: How to Cycle It, Timing & What to Expect

A Sermorelin protocol typically runs three to six months, dosed once nightly via subcutaneous injection on a five-days-on, two-days-off weekly schedule. The cycle moves through a titration shape: starting at a conservative initiation level, stepping up over the first several weeks as the body adjusts, then holding steady at a working level through the rest of the active cycle. After a full cycle, most protocols include a one to three month off-cycle break before restarting. The exact dose is determined by your goal, your individual IGF-1 response, and clinical factors, and is built for you in the MyPeptidePal Protocol Creator rather than set as a fixed number here.

Protocols By Compound 11 min read

Semaglutide + Cagrilintide Protocol: How to Cycle It, Timing & What to Expect

A semaglutide + cagrilintide protocol runs as a single long arc: a 16-week titration phase where both compounds are gradually escalated in tandem, followed by a 52-week maintenance phase at the full dose, all administered as one subcutaneous injection per week. There is no planned off-cycle break in the clinical design; this combination is built for continuous long-term use, not a short peptide cycle with a rest period. The dose moves through five steps over the titration phase, increasing every four weeks, and the specific dose at each step is what the MyPeptidePal Protocol Creator builds for you based on your goals and history. This guide covers the full cycle structure, timing principles, what to expect week by week, and the common mistakes that derail the protocol before results arrive.

Protocols By Compound 11 min read